Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Life Sciences
|
November 23, 1987
MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic mice
T T Yen
Obesity Research
|
September 1, 1994
Antiobesity and antidiabetic beta-agonists: lessons learned and questions to be answered
T T Yen
International Journal of Obesity
|
January 1, 1984
The antiobesity and metabolic activities of LY79771 in obese and normal mice
T T Yen
Obesity Research
|
November 1, 1995
Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents
T T Yen
Acta Physiologica Hungarica
|
January 1, 1992
Extension of lifespan in mice treated with Dinh lang (Policias fruticosum L.) and (-)deprenyl
T T Yen, J Knoll
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1979
Nylidrin: a potent anti-hypertensive agent in hypertensive rats
T T Yen, D V Pearson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
June 1, 1972
Locomotor activity of various types of genetically obese mice
T T Yen, J M Acton
Journal of Medicinal Chemistry
|
October 1, 1989
Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides
S J Dominianni, T T Yen
The American Journal of Clinical Nutrition
|
January 1, 1992
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
T T Yen, R W Fuller
Annals of the New York Academy of Sciences
|
January 1, 1987
The place of animal models and animal experimentation in the study of food intake regulation and obesity in humans
R W Fuller, T T Yen
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Life Sciences
|
November 23, 1987
MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic mice
T T Yen
Obesity Research
|
September 1, 1994
Antiobesity and antidiabetic beta-agonists: lessons learned and questions to be answered
T T Yen
International Journal of Obesity
|
January 1, 1984
The antiobesity and metabolic activities of LY79771 in obese and normal mice
T T Yen
Obesity Research
|
November 1, 1995
Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents
T T Yen
Acta Physiologica Hungarica
|
January 1, 1992
Extension of lifespan in mice treated with Dinh lang (Policias fruticosum L.) and (-)deprenyl
T T Yen, J Knoll
Research Communications in Chemical Pathology and Pharmacology
|
January 1, 1979
Nylidrin: a potent anti-hypertensive agent in hypertensive rats
T T Yen, D V Pearson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
June 1, 1972
Locomotor activity of various types of genetically obese mice
T T Yen, J M Acton
Journal of Medicinal Chemistry
|
October 1, 1989
Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides
S J Dominianni, T T Yen
The American Journal of Clinical Nutrition
|
January 1, 1992
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
T T Yen, R W Fuller
Annals of the New York Academy of Sciences
|
January 1, 1987
The place of animal models and animal experimentation in the study of food intake regulation and obesity in humans
R W Fuller, T T Yen
Page
of 9